Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events

被引:25
|
作者
Simon, Tobias [1 ]
Becker, Ruediger [1 ]
Voss, Frederik [1 ]
Bikou, Olympia [1 ]
Hauck, Melanie [1 ]
Licka, Manuela [1 ]
Katus, Hugo A. [1 ]
Bauer, Alexander [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
nonischemic cardiomyopathy; risk stratification; non sustained ventricular tachycardias; NT-pro BNP; sudden cardiac death;
D O I
10.1007/s00392-007-0629-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with nonischemic cardiomyopathy (DCM) are at high risk for sudden cardiac death (SCD). However, the predictive value of prophylactic implantation of implantable cardioverter defibrillators (ICD) in this patient cohort is yet unclear. Methods and Results: Whether NT pro BNP levels and/or reproducible non sustained ventricular tachycardias (NSVTs) are predictive for SCD was prospectively tested in 30 patients with DCM and LVEF <= 40%. All patients received Holter-recordings (HR) on three consecutive days and baseline NT-pro BNP levels were determined. Patients were followed for occurrence of ventricular tachyarrhythmias or unexplained syncope. A great degree of variability was found regarding the occurrence of NSVTs (10% had NSVTs in two consecutive HR, 10% in three consecutive HR, 30% in one HR and 50% had no NSVTs). Patients with NSVTs in more than one HR had significantly higher NT-pro BNP levels (first quartile: 715 pg/ml, median 2,176 pg/ml, third quartile 5,755 pg/ml vs. first quartile 273 pg/ml, median 566 pg/ml, third quartile 1,350 pg/ml, P = 0.0388). During a mean follow-up of 21.6 +/- 1.2 months patients with an arrhythmic event had significantly higher NT-pro BNP levels than patients without event (first quartile: 1,002 pg/ml, median 4,075 pg/ml, third quartile 7,777 pg/ml vs. first quartile 173 pg/ml, median 267 pg/ml, third quartile 1,220 pg/ml, P = 0.0135). NT-pro BNP levels of 2,259 pg/ml were identified as optimal cut-off value for the prediction of arrhythmic events (P = 0.0313). In contrast reproducible NSVTs were not predictive for arrhythmic events (P = 0.0960). Conclusion: The present study demonstrates that in patients with DCM the value of reproducible NSVTs in predicting arrhythmic events is low. In contrast raised NT-pro BNP levels significantly correlated with occurrence of symptomatic ventricular arrhythmias. Larger prospective trials are required to confirm these results.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 50 条
  • [31] B-type natriuretic peptide levels in atrial fibrillation
    Chen, PS
    HEART RHYTHM, 2005, 2 (11) : 1274 - 1274
  • [32] B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery
    Hsu, Jong-Hau
    Keller, Roberta L.
    Chikovani, Ornar
    Cheng, Henry
    Hollander, Seth A.
    Karl, Tom R.
    Azakie, Anthony
    Adatia, Ian
    Oishi, Peter
    Fineman, Jeffrey R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 45 - 46
  • [33] Idiopathic pulmonary fibrosis with elevated B-type natriuretic peptide
    Safley, DM
    Forker, A
    CHEST, 2003, 124 (04) : 260S - 261S
  • [34] Scal polymorphism of the atrial natriuretic peptide gene is associated with elevated levels of A- and B-type natriuretic peptide concentration in heart failure patients
    Vassalle, C.
    Prontera, C.
    Passino, C.
    Zyw, L.
    Andreassi, M. G.
    Zucchelli, G. C.
    Emdin, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 578 - 578
  • [35] Electrocardiographic patterns of hypertrophy and strain correlate with plasma B-type natriuretic peptide levels in patients with hypertrophic cardiomyopathy
    Wachowiak-Baszynska, H.
    Oko-Sarnowska, Z.
    Straburzynska-Migaj, E.
    Katarzynska-Szymanska, A.
    Ochotny, R.
    Baszczuk, A.
    Kopczynski, Z.
    EUROPEAN HEART JOURNAL, 2008, 29 : 34 - 35
  • [36] Preoperative levels of B-Type natriuretic peptide, and not inflammation, can predict an adverse outcome among patients with ischemic cardiomyopathy undergoing heart surgery
    Ganem, Fernando
    Fernandes, Juliano L.
    Blotta, Maria H.
    Auler, Jose O., Jr.
    Souza, Juliana A.
    Nicolau, Jose C.
    Hueb, Whady A.
    Serrano, Carlos V., Jr.
    CIRCULATION, 2006, 114 (18) : 476 - 476
  • [37] Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide
    McNairy, M
    Gardetto, N
    Clopton, P
    Garcia, A
    Krishnaswamy, P
    Kazanegra, R
    Ziegler, M
    Maisel, AS
    AMERICAN HEART JOURNAL, 2002, 143 (03) : 406 - 411
  • [38] Prognostic Implications of Point-of-Care and Serial B-type Natriuretic Peptide Levels in Patients With Hypertrophic Cardiomyopathy
    Siriwardena, Maithri
    Bagai, Akshay
    Delgado, Diego
    Ross, Heather J.
    Rozenblyum, Evelyn
    Rakowski, Harry
    Woo, Anna
    Thavendiranathan, Paaladinesh
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (08): : 1421 - 1428
  • [39] Increasing B-Type natriuretic peptide levels predict mortality in unselected hemodialysis patients - the cardiorenal syndrome type IV
    Breidthardt, T.
    Kalbermatter, S.
    Socrates, T.
    Noveanu, M.
    Egli, P.
    Mebazaa, A.
    Mueller, C.
    Kiss, D.
    SWISS MEDICAL WEEKLY, 2009, 139 (45-46) : 9S - 9S
  • [40] Elevated B-type natriuretic peptide levels reflect cardiac dysfunction in patients with pulmonary disease and sleep apnea
    Chillar, P
    Kushnir, C
    Chiu, A
    Maisel, A
    CIRCULATION, 2002, 106 (19) : 565 - 565